Retraining the brain to see again: a new hope for Stroke-Related blindness

NCT ID NCT05098236

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 25, 2026 · Last updated Aug 26, 2026 · Updated 1 time

Summary

This study tests whether intensive visual retraining at home can help people who have lost part of their vision due to damage to the brain's visual cortex, often from a stroke. Participants will use a computer program to practice detecting motion and orientation of visual stimuli in their blind field, with sessions one to two times daily. The goal is to see if this training can improve visual perception and whether any gains carry over to everyday vision. The study involves 280 participants and measures changes in visual abilities over up to a year.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A computer-based visual training program used at home, involving repeated tasks to discriminate motion or orientation of visual stimuli in the blind field.
What this could lead to
If effective, this training could offer a non-invasive way to partially restore vision in people with visual field loss after brain damage, improving daily functioning.
What could go wrong
The training may not work for everyone, and results are uncertain because the study is early and relies on self-reported home practice. There is also a risk of no significant improvement in real-world vision.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

280 people

The number who actually took part.

Started

Sep 2003

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

17 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Cortically Blind Subject Inclusion Criteria: * Subjects between the ages of 17 and 75, who have sustained damage to primary visual cortex at age 17 or later, and are rendered blind over a portion of their visual field. * Subjects must have some intact visual cortical areas (other than primary visual cortex) in the damaged brain hemisphere. This assessment will be made from MRI or CT scans of the subject's head, which will be obtained via standard release from their neurologist. * Subjects who demonstrate a clear deficit in either simple or complex visual perception in portions of their visual field. * Subjects who are competent and responsible, as determined by the Principal Investigator. * Subjects who will receive retinal electrophysiology (mfERG) testing must have a report from their ophthalmologist stating that they are able to receive dilating drops Cortically Blind Subject Exclusion Criteria: * Subjects who do not possess damage of primary visual cortex or its immediate afferents * Subjects who are suffering from an active disease process involving their nervous system. * Subjects who are unable to fixate visual targets precisely with their eyes * Subjects who have unreliable vision fields from prior testing indicated by greater than 20% fixation losses, false positives or false negatives * Best corrected visual acuity worse than 20/40 in either eye * Impaired foveal sensitivity as indicated by visual field tests * Presence of vision loss from ocular disease or disorder * Presence of bilateral visual acuity loss from any source * Subjects who are suffering from one-sided attentional neglect * Subjects who have impaired auditory thresholds that would influence test results and training efficacy (all our testing and training involves sound as a cue for trial/stimulus onset or as feedback) * Persons who lack the competence or are otherwise unable to perform the visual training exercises as directed. Control Subject Inclusion Criteria: * Subjects must be between the ages of 17 and 75 years of age * Subjects must report no history of neurological disorder. * Subjects who are competent and responsible, as determined by the Principal Investigator. Control Subject Exclusion criteria: * Subjects who possess damage to the visual system * Subjects who are suffering from an active disease process involving their nervous system. * Subjects who are unable to fixate visual targets precisely with their eyes * Best corrected visual acuity worse than 20/40 in either eye * Presence of vision loss from ocular disease or disorder * Presence of bilateral visual acuity loss from any source * Subjects who are suffering from one-sided attentional neglect * Subjects who have impaired auditory thresholds that would influence test results and training efficacy (all our testing and training involves sound as a cue for trial/stimulus onset or as feedback) * Persons who lack the competence or are otherwise unable to perform the visual testing/training exercises as directed.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cortical blindness are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Flaum Eye Institute, University of Rochester Medical Center

    Rochester, New York, 14642, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.